Shire CEO Orn­skov woos Bay­er’s An­dreas Busch to run Boston-based R&D group

We now know where Bay­er’s dis­cov­ery chief, An­dreas Busch, is head­ed.

Shire’s Flem­ming Orn­skov has re­cruit­ed Busch as his new R&D chief and chief sci­en­tif­ic of­fi­cer, hand­ing him the reins for the pipeline as the CEO com­pletes a mis­sion to re­make Shire in­to a rare dis­ease spe­cial­ist. And the up­ward­ly mo­bile Busch will now join the world­wide mi­gra­tion of tal­ent and mon­ey in­to the Cam­bridge, MA hub where Shire has been plan­ning a big move.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER